Joel Schneider's most recent trade in Solid Biosciences Inc was a trade of 15,272 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,272 | 236,270 (0%) | 0% | 1.1 | 16,799 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,232 | 251,542 (0%) | 0% | 1.1 | 16,755 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 180,000 | 180,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 90,000 | 90,000 | - | - | Restricted Stock Units |